Related Experiment Videos
Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications
Chest
|March 1, 1990
Summary
Antibiotic distribution in heart valve infections is poorly understood. Computer models show standard amikacin doses fail to reach therapeutic levels in vegetation centers, suggesting higher doses are needed for effective endocarditis treatment.
Area of Science:
- Pharmacology
- Infectious Diseases
- Computational Biology
Background:
- Antibiotic penetration into cardiac vegetations is crucial for treating infective endocarditis but remains poorly understood.
- Aminoglycosides are vital in endocarditis therapy, yet their distribution within valvular tissues is not well characterized.
Purpose of the Study:
- To characterize aminoglycoside distribution within aortic vegetations using integrative computer modeling.
- To evaluate the impact of standard versus high-dose amikacin regimens on drug levels within experimental vegetations.
- To simulate aminoglycoside penetration in human aortic vegetations based on rabbit endocarditis data.
Main Methods:
- Integrative computer modeling utilizing pharmacokinetic data from experimental endocarditis.
- Calculation of drug distribution in various geographic sectors of aortic vegetations in rabbits and simulated human models.
- Comparison of drug concentrations against minimum bactericidal concentrations (MBC) in plasma and vegetation.
Main Results:
- Standard amikacin regimens achieved sub-minimum bactericidal concentration (sub-MBC) levels in the center of rabbit vegetations, despite supra-MBC levels in plasma.
- High-dose amikacin (40 mg/kg) achieved supra-MBC levels throughout rabbit vegetations for at least 50% of the dosing interval.
- Simulations indicated that even high-dose aminoglycoside regimens often failed to achieve uniform supra-MBC levels within simulated 10-mm human vegetations.
Conclusions:
- Aminoglycoside distribution in aortic endocarditis is suboptimal, with poor penetration into vegetation centers.
- Higher-than-recommended daily doses of aminoglycosides may be necessary to achieve therapeutic intravegetation levels.
- These findings support further investigation into high-dose aminoglycoside regimens for experimental endocarditis treatment.